Department of Pediatrics, School of Medicine, University of New Mexico, Albuquerque, NM, USA.
Substance Use Research and Education (SURE) Center, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA.
Pediatr Res. 2024 Jul;96(2):471-479. doi: 10.1038/s41390-022-02252-z. Epub 2022 Aug 10.
With significant increases in opioid use/misuse and persistent high prevalence of prenatal alcohol exposure (PAE), identifying infants at risk for long-term developmental sequelae due to these exposures remains an urgent need. This study reports on developmental outcomes in young children from a prospective cohort, ENRICH-1, which recruited pregnant women and followed up maternal-infant pairs.
Subjects were assigned to four study groups based on prenatal use of medications for opioid use disorder (MOUD), PAE, MOUD+PAE, and unexposed controls (UC). Mixed effects modeling was used to evaluate changes in the Bayley Scales of Infant Development-III (BSID-III) Cognitive, Language, and Motor scores between 6 and 20 months.
There was a significant three-way interaction (MOUD-by-PAE-by-Time) with respect to the BSID-III Cognitive (p = 0.045) and Motor (p = 0.033) scales. Significant changes between the two evaluations were observed for MOUD group in Cognitive and Language scores; for PAE group in Cognitive, Language, and Motor scores, and for MOUD+PAE group in Language scores after adjusting for child sex and family socio-economic status. The developmental scores for the UC remained stable.
Observed decline in neurodevelopmental scores during the first 2 years of life emphasizes the importance of a longitudinal approach when evaluating children with prenatal polysubstance exposure.
BSID-III scores were stable during the first 2 years of life for unexposed children. BSID-III scores declined for children with prenatal exposures to alcohol and/or opioids. Standard developmental tests may not be sensitive enough during the first year of life. Findings emphasize the need for repeated evaluations of children who are at high risk.
随着阿片类药物使用/滥用的显著增加和产前酒精暴露(PAE)的持续高发,识别因这些暴露而面临长期发育后遗症风险的婴儿仍然是当务之急。本研究报告了一项前瞻性队列研究 ENRICH-1 中幼儿的发育结果,该研究招募了孕妇并对母婴对进行了随访。
根据孕妇在怀孕期间使用治疗阿片类药物使用障碍(MOUD)、PAE、MOUD+PAE 的情况和未暴露的对照组(UC),将受试者分为四组。使用混合效应模型评估了 6 至 20 个月之间婴儿发展量表第三版(BSID-III)认知、语言和运动评分的变化。
BSID-III 认知(p=0.045)和运动(p=0.033)量表的 MOUD- PAE-时间三向交互作用具有统计学意义。在调整了儿童性别和家庭社会经济地位后,MOUD 组在认知和语言评分中,PAE 组在认知、语言和运动评分中,以及 MOUD+PAE 组在语言评分中观察到两次评估之间的显著变化,UC 的发育评分保持稳定。
在生命的前 2 年观察到神经发育评分下降,强调了在评估产前多物质暴露儿童时采用纵向方法的重要性。
未暴露儿童的 BSID-III 评分在生命的前 2 年保持稳定。BSID-III 评分在产前接触酒精和/或阿片类药物的儿童中下降。标准发育测试在生命的第一年可能不够敏感。这些发现强调了需要对高风险儿童进行重复评估。